Tenax TherapeuticsTENX
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 26 institutions reported holding Tenax Therapeutics Inc. (TENX) in their 13F filings, up 3 from Q1 2025. 3 opened new positions and 0 sold out. The largest holders were RTW Investments, LP ($2.2M), BVF Inc. ($2.0M) and Millennium Management ($1.4M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Tenax Therapeutics Inc.
- CUSIP
- 88032L605
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $9K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 354,307 shares bought and 128,757 shares sold, net +225,550 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| RTW Investments, LP | 0.03% | No change | 378,346 | $2.2M |
| BVF Inc. | 0.07% | No change | 339,549 | $2.0M |
| Millennium Management | 0.00% | Add +777.8% | 233,714 | $1.4M |
| Vivo Capital, LLC | 0.12% | No change | 208,333 | $1.2M |
| Morgan Stanley | 0.00% | Add +47.0% | 178,010 | $1.0M |
| Janus Henderson Group PLC | 0.00% | No change | 166,666 | $978K |
| Integral Health Asset Management, LLC | 0.09% | No change | 167,000 | $962K |
| ADAR1 Capital Management, LLC | 0.15% | Add +126.3% | 155,557 | $896K |
| Venrock Adviser, LLC | 0.04% | Reduce -52.7% | 98,564 | $568K |
| Velan Capital Investment Management LP | 0.48% | No change | 83,333 | $480K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 83,333 | $480K |
| Vestal Point Capital, LP | 0.02% | No change | 53,439 | $308K |
| Geode Capital Management, LLC | 0.00% | Add +2.7% | 34,236 | $200K |
| Vanguard Group Inc. | 0.00% | No change | 22,287 | $130K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -17.2% | 15,930 | $93K |
| Citadel Advisors | 0.00% | Reduce -55.3% | 10,345 | $60K |
| Raymond James Financial Inc. | 0.00% | New | 1,503 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +550.5% | 1,249 | $7K |
| BlackRock, Inc. | 0.00% | No change | 300 | $2K |
| Bank of America Corp. | 0.00% | Add +8.7% | 249 | $1K |
| UBS Group AG | 0.00% | Reduce -99.5% | 14 | $81 |
| Barclays PLC | 0.00% | New | 11 | $63 |
| Jones Financial Companies LLLP | 0.00% | New | 1 | $6 |
| Allworth Financial LP | 0.00% | No change | 1 | $6 |
| Physician Wealth Advisors, Inc. | 0.00% | No change | 1 | $6 |
| Union Bancaire Privee, UBP SA | 0.00% | No change | 1 | $5 |
"% of holder's portfolio" is TENX's weight in each manager's 13F, not the share of Tenax Therapeutics Inc. the manager owns.